Related Experiment Video
Updated: Jan 17, 2026
Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS
Published on: November 26, 2018
Current Practice and Barriers to Using High-Flow Nasal Cannula Among ARDS Patients in Saudi Arabia: A Cross-Sectional
Mohammed M Alyami1, Abdulelah M Aldhahir2,3, Abdullah A Alqarni4,5
1Respiratory Therapy Department Batterjee Medical College Khamis Mushait Saudi Arabia.
Background And Aims:
High-flow nasal cannula (HFNC) is increasingly utilized in clinical practice; however, the perspectives of physicians on its use and associated barriers in managing acute respiratory distress syndrome (ARDS) in Saudi Arabia remain unexplored. This study aims to evaluate HFNC practices and identify the barriers faced by ICU and respiratory physicians in utilizing HFNC for ARDS patients.
Methods:
A cross-sectional survey was distributed between December 22, 2022, and July 15, 2023, to respiratory and ICU physicians in Saudi Arabia. Data are presented as frequencies and percentages.
Results:
A total of 987 responses were analyzed, revealing that physicians perceive HFNC as beneficial for relieving shortness of breath (686, or 69.5%), helping with speech and eating (649, or 65.8%), and potentially preventing intubation (629, or 63.7%). In terms of HFNC practice, 445 respondents (45.1%) reported that its use is governed by institutional protocols, while 679 (68.8%) indicated that the decision to initiate therapy is made by physicians. Additionally, 458 (46.4%) stated that a flow rate of ≥ 15 L/min is necessary to start HFNC therapy. When considering initial settings, nearly half (455, or 46.09%) chose a fraction of inspired oxygen (FiO2) between 61%-80%, 442 (44.8%) chose a flow between 30 and 40 L/min, and 476 (48.23%) chose a temperature of 34°C. Reducing gas flow by 5-10 L/min every two to 4 h was the most appropriate way of weaning, according to 407 (41.24%), and both FiO2 < 35% and gas flow < 20 L/min should be achieved to disconnect HFNC therapy. Lack of knowledge about HFNC therapy was the most commonly reported barrier (494, or 50.1%).
Conclusion:
Physicians demonstrated a comprehensive understanding of the potential benefits associated with HFNC therapy. However, variations in initial settings and the absence of standardized guidelines present significant challenges to its optimal application in patients with ARDS.
More Related Videos
Related Concept Videos
01:29Administering Oxygen by Nasal Cannula
Nasal Cannulas
A nasal cannula is a lightweight tube split into two prongs placed in the nostrils,...
01:26Oxygen Delivering System I: Nasal Cannula and Face Mask
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...
01:29Suctioning the Nasopharyngeal Airway
Equipment Required
01:16Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
01:30Administering Oxygen by Mask
Administering oxygen by mask is a common nursing intervention that provides supplemental oxygen to patients with respiratory distress or chronic lung conditions. This procedure involves delivering oxygen at a specified rate through a face mask connected to an oxygen source.
Equipment
The equipment necessary for this procedure includes:
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...